ARBB (ARBB) Stock Price & Analysis
ARBB (ARBB) rose 3.58% to USD 5.67 as of June 10, 2026 at 01:56 UTC, according to Nexqual real-time market data.
ARBB last closed at USD 5.47; the session ranged USD 5.36–5.67 on volume of 5,626 shares. Market capitalization is $10.00M, with a 52-week range of USD 3.71–13.89 (NCM). Source: Nexqual, June 10, 2026 at 01:56 UTC.
Key Statistics (as of June 10, 2026 at 01:56 UTC)
| Price | USD 5.67 |
|---|---|
| Change | ▲ 3.58% (up) |
| Previous Close | USD 5.47 |
| Open | USD 5.6 |
| Day Range | USD 5.36 – 5.67 |
| 52-Week Range | USD 3.71 – 13.89 |
| Volume | 5,626 shares |
| Market Cap | $10.00M |
| Exchange | NCM |
Technical Analysis (ARBB)
Nexqual's technical model rates ARBB "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 01:56 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 63.15 (neutral) |
| vs SMA50 | Above (USD 4.66) |
| MACD | 0.23 (positive) |
Analyst Ratings (ARBB)
Wall Street analysts rate ARBB "None" based on 1 analysts, with a mean price target of USD 20 (range USD 20–20), per Nexqual as of June 10, 2026 at 01:56 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 20 |
| High Target | USD 20 |
| Low Target | USD 20 |
Earnings (ARBB)
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Financials & Fundamentals (ARBB)
| Total Revenue | $197.32M |
|---|---|
| Revenue Growth (YoY) | +331.70% |
| Gross Margin | -4.13% |
| Operating Margin | -15.17% |
| Profit Margin | -36.17% |
| ROE | -31.42% |
| Debt / Equity | 0.01 |
| Current Ratio | 7.64 |
| Total Cash | $32.66M |
| Total Debt | $10,954 |
| Free Cash Flow | $12.94M |
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Financial Health Score (ARBB)
Nexqual rates ARBB's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 01:56 UTC.
| Growth | Strong — Revenue +332% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $33M cash, no debt |
| Cash Flow | Strong — FCF $13M, 28% margin |
| Efficiency | Critical — ROE -31%, ROA -12.1% |
Ownership (ARBB)
| Insider Ownership | +35.49% |
|---|---|
| Institutional Ownership | +0.05% |
| Shares Outstanding | 1.77M |
| Float | 1.14M |
| Short % of Float | +2.82% |
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Leadership (ARBB)
ARBB is led by Kok Leong Liew (age 52), Chairman of the Board & CEO, per Nexqual as of June 10, 2026 at 01:56 UTC.
| Chairman of the Board & CEO | Kok Leong Liew (age 52) |
|---|---|
| CFO & Director | Kok Wah Ng (age 47) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BGLC | BioNexus Gene Lab Corp | USD 2.18 | ▼ 1.14% |
| MGIH | Millennium Group International | USD 1.69 | ▲ 19.86% |
| OMH | Ohmyhome Limited | USD 0.61 | ▼ 12.7% |
| VCIG | VCI Global Limited | USD 6.04 | ▼ 14.81% |
| ACON | Aclarion, Inc. | USD 3.26 | ▼ 8.68% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:56 UTC. This page is informational and not investment advice.